Physician profile
Gregory Robbe Jackson
NPI 1114922036
$1,387.28
in general payments reported to CMS, 2019-2025
17 companies · $281 in 2025
The $281 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $413 · 2020: $95.42 · 2021: $198 · 2022: $147 · 2023: $144 · 2024: $110 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $516 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $516.31 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $354.67 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $174.20 | 2022-2024 | Infuse, Miebo |
| Coopervision INC. | $161.09 | 2020-2025 | Myday Contact Lens, Clariti Contact Lens |
| Optos, INC. | $134.07 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $104.59 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $93.66 | 2019-2023 | Total30 |
| Allergan, INC. | $83.35 | 2020-2022 | |
| Dompe US, INC. | $54.06 | 2025 | Oxervate |
| Novartis Pharmaceuticals Corporation | $49.72 | 2019-2022 | |
| Abbvie INC. | $34.19 | 2025 | |
| Aerie Pharmaceuticals, INC. | $29.22 | 2019 | |
| Astellas Pharma US INC | $25.60 | 2025 | Izervay |
| Johnson & Johnson Vision Care, INC. | $25.27 | 2022 | |
| Ani Pharmaceuticals, INC. | $18.38 | 2025 | Purified Cortrophin Gel |
| Shire North American Group INC | $16.69 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $16.51 | 2025 | Tepezza |
| Kala Pharmaceuticals, INC. | $12.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.